Jian‐Di Li

577 total citations
48 papers, 360 citations indexed

About

Jian‐Di Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jian‐Di Li has authored 48 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 15 papers in Cancer Research and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jian‐Di Li's work include RNA modifications and cancer (14 papers), Ferroptosis and cancer prognosis (11 papers) and Epigenetics and DNA Methylation (6 papers). Jian‐Di Li is often cited by papers focused on RNA modifications and cancer (14 papers), Ferroptosis and cancer prognosis (11 papers) and Epigenetics and DNA Methylation (6 papers). Jian‐Di Li collaborates with scholars based in China, United States and Greece. Jian‐Di Li's co-authors include Gang Chen, Aijun Gong, Lina Qiu, Rong‐Quan He, Fukai Li, Minhua Rong, Weiwei Zhang, Yi‐Wu Dang, Zhi‐Guang Huang and Jingrui Li and has published in prestigious journals such as Journal of Chromatography A, Marine Pollution Bulletin and Sensors.

In The Last Decade

Jian‐Di Li

40 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jian‐Di Li China 11 156 109 57 56 50 48 360
Jiali Jin China 8 178 1.1× 120 1.1× 135 2.4× 28 0.5× 29 0.6× 16 412
Yuqin Tang China 13 144 0.9× 70 0.6× 87 1.5× 23 0.4× 43 0.9× 36 481
Yixuan Yao China 9 113 0.7× 65 0.6× 27 0.5× 38 0.7× 90 1.8× 23 425
Vladan Milošević Serbia 13 83 0.5× 28 0.3× 31 0.5× 64 1.1× 79 1.6× 24 325
Xintian Chen China 11 257 1.6× 97 0.9× 27 0.5× 31 0.6× 38 0.8× 17 487
Guoxia Li China 13 196 1.3× 77 0.7× 12 0.2× 27 0.5× 77 1.5× 48 585
Xinglin Chen China 13 213 1.4× 129 1.2× 188 3.3× 19 0.3× 98 2.0× 32 587
Yaling Wang China 12 199 1.3× 122 1.1× 20 0.4× 28 0.5× 40 0.8× 21 392
Weibo Feng China 16 300 1.9× 189 1.7× 77 1.4× 27 0.5× 142 2.8× 30 670

Countries citing papers authored by Jian‐Di Li

Since Specialization
Citations

This map shows the geographic impact of Jian‐Di Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian‐Di Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian‐Di Li more than expected).

Fields of papers citing papers by Jian‐Di Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian‐Di Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian‐Di Li. The network helps show where Jian‐Di Li may publish in the future.

Co-authorship network of co-authors of Jian‐Di Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jian‐Di Li. A scholar is included among the top collaborators of Jian‐Di Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jian‐Di Li. Jian‐Di Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Jian‐Di, et al.. (2024). Different biological responses of Skeletonema costatum and Prorocentrum donghaiense to polymetallic nodules from seawaters. Aquatic Toxicology. 269. 106871–106871. 2 indexed citations
2.
3.
Li, Dongming, Guosheng Li, Jian‐Di Li, et al.. (2024). Clinical significance and prospective mechanism of increased CDKN2A expression in small cell lung cancer. Clinical & Translational Oncology. 26(6). 1519–1531. 2 indexed citations
4.
Chen, Jingyu, et al.. (2024). Bibliometric analysis of phosphoglycerate kinase 1 expression in breast cancer and its distinct upregulation in triple-negative breast cancer. World Journal of Clinical Oncology. 15(7). 867–894. 2 indexed citations
5.
Liang, Liang, Jian‐Di Li, Rong‐Quan He, et al.. (2023). LPCAT1 enhances the invasion and migration in gastric cancer: Based on computational biology methods and in vitro experiments. Cancer Medicine. 12(12). 13438–13454. 3 indexed citations
6.
Li, Jian‐Di, Yi Chen, Yuhong Zhou, et al.. (2023). Triosephosphate isomerase 1 may be a risk predictor in laryngeal squamous cell carcinoma: a multi-centered study integrating bulk RNA, single-cell RNA, and protein immunohistochemistry. European journal of medical research. 28(1). 591–591. 5 indexed citations
7.
Chen, Gang, et al.. (2022). Downregulated miR-150-5p in the Tissue of Nasopharyngeal Carcinoma. Genetics Research. 2022. 1–13. 1 indexed citations
8.
Chen, Gang, Jian‐Di Li, Zhi‐Guang Huang, et al.. (2022). Potential Molecular Mechanism of Upregulated Aryl Hydrocarbon Receptor Nuclear Translocator 2 in Nasopharyngeal Carcinoma. Computational and Mathematical Methods in Medicine. 2022. 1–20. 1 indexed citations
9.
Li, Jian‐Di, Gang Chen, Rong‐Quan He, et al.. (2022). Role of Up-Regulated Transmembrane Channel-Like Protein 5 in Pancreatic Adenocarcinoma. Digestive Diseases and Sciences. 68(5). 1894–1912. 5 indexed citations
10.
Fang, Ye‐Ying, Jian‐Di Li, Heqing Huang, et al.. (2022). AZGP1 Up-Regulation is a Potential Target for Andrographolide Reversing Radioresistance of Colorectal Cancer. Pharmacogenomics and Personalized Medicine. Volume 15. 999–1017. 4 indexed citations
11.
Chen, Gang, Rong‐Quan He, Zhi‐Guang Huang, et al.. (2022). Expression of IER3 in hepatocellular carcinoma: clinicopathology, prognosis, and potential regulatory pathways. PeerJ. 10. e12944–e12944. 6 indexed citations
12.
Tang, Wei, Jian‐Di Li, Rong‐Quan He, et al.. (2022). Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients. PeerJ. 10. e13708–e13708. 4 indexed citations
13.
14.
Rong, Minhua, Jian‐Di Li, Yuzhen Huang, et al.. (2021). CCNB1 promotes the development of hepatocellular carcinoma by mediating DNA replication in the cell cycle. Experimental Biology and Medicine. 247(5). 395–408. 29 indexed citations
15.
Lu, Huiping, Jian‐Di Li, Gang Chen, et al.. (2021). Clinical Implication of E2F Transcription Factor 1 in Hepatocellular Carcinoma Tissues. Cancer Biotherapy and Radiopharmaceuticals. 38(10). 684–707. 6 indexed citations
16.
Qiu, Lina, Jian‐Di Li, Weiwei Zhang, et al.. (2021). Extraction and Back-Extraction Behaviors of La(III), Ce(III), Pr(III), and Nd(III) Single Rare Earth and Mixed Rare Earth by TODGA. Sensors. 21(24). 8316–8316. 6 indexed citations
17.
Qiu, Lina, Weiwei Zhang, Aijun Gong, & Jian‐Di Li. (2021). Isolation and identification of a 2,3,7,8-Tetrachlorodibenzo-P-dioxin degrading strain and its biochemical degradation pathway. Journal of Environmental Health Science and Engineering. 19(1). 541–551. 6 indexed citations
18.
Gao, Li, Guosheng Li, Jian‐Di Li, et al.. (2021). Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods. Computational and Structural Biotechnology Journal. 19. 6229–6239. 15 indexed citations
19.
Li, Jian‐Di, Gang Chen, Mei Wu, Yu Huang, & Wei Tang. (2020). Downregulation of CDC14B in 5218 breast cancer patients: A novel prognosticator for triple-negative breast cancer. Mathematical Biosciences & Engineering. 17(6). 8152–8181. 4 indexed citations
20.
Li, Jingrui, Aijun Gong, Lina Qiu, et al.. (2020). Selective extraction and column separation for 16 kinds of rare earth element ions by using N, N-dioctyl diglycolacid grafted silica gel particles as the stationary phase. Journal of Chromatography A. 1627. 461393–461393. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiali Jin Breakdown of academic impact, for papers by Yuqin Tang Breakdown of academic impact, for papers by Yixuan Yao Breakdown of academic impact, for papers by Vladan Milošević Breakdown of academic impact, for papers by Xintian Chen Breakdown of academic impact, for papers by Guoxia Li Breakdown of academic impact, for papers by Xinglin Chen Breakdown of academic impact, for papers by Yaling Wang Breakdown of academic impact, for papers by Weibo Feng
Rankless by CCL
2026